TEL AVIV, Israel and SEATTLE, Wash., June 23, 2021 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd. (NASDAQ: CMMB), a clinical-stage biotech company focused on the discovery and development of ...
Sign up for our newsletter to get the latest on the transformative forces shaping the global economy, delivered every Thursday.
AGC Biologics to manufacture CM-101 for Phase II/III trials at their Copenhagen facility TEL AVIV, Israel and SEATTLE, Wash., June 23, 2021 (GLOBE NEWSWIRE) -- Chemomab Therapeutics, Ltd. (NASDAQ: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results